Novartis GCC in India

About Novartis's India GCC

Novartis operates one of its largest Global Capability Centers (GCCs) in Hyderabad at the Novartis Corporate Center (NOCC) and Genome Valley, along with a more recent hub in Mumbai. Today, the India hub is a critical base supporting the development journey of breakthrough medicines across multiple therapy areas including cardiovascular, oncology, immunology, neurology, and global health. The center plays a strategic role in enabling end-to-end global drug development, providing capabilities in Global Clinical Operations, Technical R&D, Patient Safety & Pharmacovigilance, Regulatory Affairs, and Advanced Quantitative Sciences.The Novartis Corporate Center India (NOCC), the largest of Novartis’ six global hubs, functions as a comprehensive Global Capability Center supporting the company’s worldwide operations. Its scope spans three pillars: Development Hub – Driving global drug development through clinical operations, technical R&D, patient safety, pharmacovigilance, regulatory affairs, analytics, and clinical development. Biomedical Research – Advancing discovery science by strengthening capabilities that contribute to next-generation medicines globally. Operations & Enterprise Services – Delivering shared services across business functions such as IT, data and digital, manufacturing supply, quality, procurement, HR, finance, legal, risk and compliance, and communications.

Where Novartis operates in India

• Hyderabad: all GCCs in Hyderabad
• Mumbai: all GCCs in Mumbai

What the center does

• Innovation and R&D Center
• GBS/Shared Services
• Digital Transformation/Technology Center

Industry: Pharmaceutical Manufacturing